France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines

Regulations
May.25
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).

Key Points

  • France bans Zyn products;
  • Possession now criminalized;
  • Fines up to $436,600;
  • Sweden criticizes French ban.

2Firsts

May 25, 2026

According to the New York Post, France’s health ministry has officially banned nicotine pouches and other oral nicotine products, including Zyn.

Under the new regulation, the ban applies to:

  • use;
  • purchase;
  • possession;
  • and sale

of oral nicotine products.

Violators may face:

  • up to five years in prison;
  • and fines of up to €400,000 (approximately $436,600).

The report said the ban covers:

  • nicotine pouches;
  • nicotine gum lozenges;
  • and other oral nicotine products.

This includes Zyn, the Swedish-origin nicotine pouch brand that has rapidly gained popularity across Europe and the United States.

France’s health ministry said the regulation officially took effect on April 1, 2026.

However, traditional cigarettes and vaping products are currently excluded from the ban.

French authorities classified nicotine as a “toxic substance.”

The government said such products may lead to:

  • nicotine addiction;
  • acute nicotinic syndromes;
  • severe vomiting;
  • dehydration;
  • seizures;
  • and other health risks.

French officials also cited a 2023 report by the French Agency for Food, Environmental and Occupational Health & Safety (ANSES), which warned that nicotine pouch marketing had become widespread across social media and may target younger consumers.

The report noted that France has become the first European country to criminalize both possession and use of nicotine pouch products.

Countries including Austria, Belgium, Germany, Luxembourg, and the Netherlands have previously introduced bans or strict restrictions on nicotine pouch sales.

However, most European countries have focused on restricting commercial sales rather than criminalizing individual possession or use.

The French ban has also triggered criticism from Sweden.

Swedish Trade Minister Benjamin Dousa told the Financial Times:

“It is absurd.”

He compared the French ban to Sweden banning French baguettes or French wine.

The Swedish government has repeatedly criticized France’s nicotine pouch restrictions and argued that the measures may conflict with European Union single-market principles.

Nicotine pouch products have expanded rapidly across Western markets in recent years.

According to the U.S. National Youth Tobacco Survey, nicotine pouches became the second most commonly used tobacco-related product among American minors in 2024, behind only e-cigarettes.

Industry observers said France’s sweeping restrictions may further deepen regulatory divisions across Europe regarding nicotine pouch policy.

(Cover Image source: New York Post)


2FIRSTS | Swedish Politicians Ask European Commission to Clarify Legality of France’s Nicotine Pouch Ban
2FIRSTS | Swedish Politicians Ask European Commission to Clarify Legality of France’s Nicotine Pouch Ban
France’s ban on oral nicotine pouches has triggered an immediate response in Sweden. Swedish Minister for Foreign Trade Benjamin Dousa said Sweden had mobilized strongly against the ban and argued that it constitutes a clear obstacle to the free movement of goods within the EU single market. Swedish officials say the measure affects a strategically important domestic industry and conflicts with Sweden’s harm-reduction approach to public health.
www.2firsts.com

2FIRSTS | France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
2FIRSTS | France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s top health agency has confirmed that vaping is less harmful than smoking — but not risk-free — reshaping the country’s regulatory trajectory. As Paris withdraws a proposed vape tax and debates stricter ingredient, emissions and youth-protection rules, the ANSES report signals not prohibition, but tighter technical oversight. For manufacturers, retailers and EU policymakers, France may be previewing Europe’s next phase of nicotine governance.
www.2firsts.com


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Related Topics